FourWorld Capital Management »

Augmedix shares owned by FourWorld Capital Management

Quarter-by-quarter ownership of Augmedix (AUGX) shares owned by FourWorld Capital Management from 13F filings

Historical chart of FourWorld Capital Management investment in Augmedix

Tip: Access up to 7 years of quarterly data

All positions including Augmedix held by FourWorld Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Augmedix by FourWorld Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $207k 51k 4.09

More positions owned by FourWorld Capital Management

TDCX Ads (TDCX)
Seritage Growth Pptys Cl A (SRG)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Hollysys Automation Tchngy L SHS (HOLI)
Odyssey Marine Expl Com New (OMEX)
Arbutus Biopharma (ABUS)
Cytokinetics Com New Call Option (CYTK)
iRobot Corporation Put Option (IRBT)
Tevogen Bio Hldgs *w Exp 02/14/202 (TVGNW)
Bristol-myers Squibb Right 12/30/2030 (CELG.R)
Albertsons Cos Common Stock (ACI)
Evolv Technologies Hldngs In Com Cl A (EVLV)
Evolus (EOLS)
Vaneck Etf Trust Junior Gold Mine (GDXJ)
Ferroglobe SHS (GSM)

View all positions for FourWorld Capital Management

Top funds holding Augmedix

Redmile Group
Samjo Management
Citadel Advisors
Perkins Capital Management
Vanguard Group
Schonfeld Strategic Advisors
Balyasny Asset Management
Trium Capital
G2 Investment Partners Management
Luminus Management
Russell Investments
Parkman Healthcare Partners
American Financial Group
Geode Capital Management
Millennium Management

View all funds holding Augmedix